During chronic brucellosis, Brucella melitensis persists in the spleen inside a phenotypically distinctive myeloid population: CD11c⁺CD205⁺ cells that express arginase-1, accumulate neutral lipids, yet lack markers of Th2 (T-helper-2)-induced alternatively activated (M2a) macrophages and do not require STAT6. Whether the arginase-1 activity (through reduced nitric oxide and polyamine synthesis) and the stored lipids of these specific cells directly promote bacterial growth or latency, what their developmental origin is, and which STAT6-independent signals polarize them remain unresolved; only the systemic arginase-1/polyamine contribution to chronicity has since been established in the related alternatively-activated-macrophage niche. The problem is to experimentally establish the cell-intrinsic nurturing mechanisms and the lineage identity of this reservoir, and to test whether targeting arginase activity or lipid metabolism can dislodge the chronic reservoir.

Background

Brucella melitensis is a facultative intracellular bacterium that causes brucellosis, one of the most widespread bacterial zoonoses; in the mouse model it establishes a chronic infection in which the spleen is the main persistence organ. Because chronically infected cells are extremely rare in immunocompetent mice, Hanot Mambres and colleagues studied the intrinsically susceptible IL-12p40⁻/⁻ BALB/c mouse (IL-12p40 being a subunit shared by interleukin-12 and interleukin-23, whose loss cripples the protective Th1 (T-helper type 1 CD4⁺ T-cell) response), infected intranasally with a B. melitensis 16M strain expressing mCherry from a single chromosomal copy so that infected cells could be visualized directly in tissue sections by immunofluorescence. In situ analysis at 28 days post-infection showed that most infected spleen cells localize in the white pulp and express CD11c (integrin αX, a dendritic-cell marker) and CD205 (DEC-205, a C-type lectin receptor on dendritic cells), that 63% express arginase-1 (the enzyme that diverts L-arginine away from nitric-oxide synthesis toward ornithine, the precursor of putrescine, spermidine and spermine — collectively polyamines), and that 91% stain with Bodipy, a fluorescent dye that marks neutral-lipid droplets. The infected cells were negative for Fizz1 and CD301, markers of alternatively activated (M2a) macrophages, and deficiency of STAT6, the transcription factor mediating IL-4/IL-13 signaling (which drives M2a polarization), changed neither the bacterial course nor the reservoir phenotype, so the cells cannot be considered classical Th2-induced M2a macrophages. Their phenotype — CD11c⁺CD205⁺, low MHC-II (the antigen-presenting molecule that splenic dendritic cells normally express at high levels), Arg1⁺, lipid-rich — is strongly reminiscent of the lipid-laden ("foamy") cells seen in Mycobacterium tuberculosis infection, and expression of MOMA-1 (a marginal metallophilic macrophage marker) or of SIGN-R1/ER-TR9 (marginal-zone macrophage markers) on a fraction of the infected CD11c⁺ cells suggested a possible marginal-zone origin. A prior study (Xavier et al. 2013) had proposed that B. abortus survives and replicates preferentially in alternatively activated macrophages, where glucose availability driven by PPARγ (peroxisome proliferator-activated receptor γ, a nuclear receptor regulating lipid and glucose metabolism) sustains chronic infection. The source paper (Hanot Mambres et al. 2015) concluded that the reservoir cells are all of myeloid origin yet phenotypically distinct from classical splenic dendritic cells and macrophages, suggesting that Brucella infection directly or indirectly drives their differentiation. The authors could not complement the microscopy with flow cytometry because the single-copy mCherry signal is too dim and Brucella-specific antibodies cannot distinguish infected cells from cells merely cross-presenting Brucella antigens — a stated limitation that left the cells' identity, origin and function open.

Problem Statement

For the splenic CD11c⁺CD205⁺ arginase-1⁺ lipid-rich myeloid reservoir cells in which Brucella melitensis persists during the chronic phase of infection (as characterized in situ in susceptible IL-12p40⁻/⁻ BALB/c mice and functionally corroborated for CD11c⁺ cells in resistant C57BL/6 mice), the problem posed by the source work is to experimentally establish: (1) the functional significance of arginase-1 expression and high lipid content in these cells for Brucella persistence — in particular whether arginase-1 activity, through reduced nitric-oxide production and polyamine synthesis, or the stored lipids directly promote bacterial growth or latency in these cells (not merely in Th2-induced alternatively activated macrophages, where the arginase-1/polyamine contribution to chronic infection has since been demonstrated); (2) the precise developmental origin and lineage relationship of the reservoir cells — whether they are an infection-driven myeloid subset distinct from classical splenic dendritic cells and macrophages, a modified dendritic-cell population, or derived from marginal-zone or marginal metallophilic macrophages; (3) the signaling pathways, acting independently of STAT6, that drive arginase-1 expression and lipid accumulation in the infected cells; and (4) whether targeting arginase activity or lipid metabolism can therapeutically dislodge the chronic splenic reservoir. These four facets jointly constitute the open problem: a resolution is expected to address all of them, and resolving any single facet leaves the others open. A resolution is a rigorous, testable experimental strategy for each facet — the proposed experiments, their predicted read-outs, and the observations that would confirm or refute the corresponding claim; producing new in vivo data is not required.

References

  1. Hanot Mambres D, Machelart A, Vanderwinden J-M, De Trez C, Ryffel B, Letesson J-J, Muraille E. In Situ Characterization of Splenic Brucella melitensis Reservoir Cells during the Chronic Phase of Infection in Susceptible Mice. PLoS ONE 2015;10(9):e0137835. doi:10.1371/journal.pone.0137835. https://doi.org/10.1371/journal.pone.0137835
  2. Copin R, Vitry M-A, Hanot Mambres D, Machelart A, De Trez C, Vanderwinden J-M, Magez S, Akira S, Ryffel B, Carlier Y, Letesson J-J, Muraille E. In Situ Microscopy Analysis Reveals Local Innate Immune Response Developed around Brucella Infected Cells in Resistant and Susceptible Mice. PLoS Pathog 2012;8(3):e1002575. doi:10.1371/journal.ppat.1002575. https://doi.org/10.1371/journal.ppat.1002575
  3. Xavier MN, Winter MG, Spees AM, den Hartigh AB, Nguyen K, Roux CM, Silva TMA, Atluri VL, Kerrinnes T, Keestra AM, Monack DM, Luciw PA, Eigenheer RA, Bäumler AJ, Santos RL, Tsolis RM. PPARγ-Mediated Increase in Glucose Availability Sustains Chronic Brucella abortus Infection in Alternatively Activated Macrophages. Cell Host Microbe 2013;14(2):159-170. doi:10.1016/j.chom.2013.07.009. https://doi.org/10.1016/j.chom.2013.07.009
  4. Kerrinnes T, Winter MG, Young BM, Diaz-Ochoa VE, Winter SE, Tsolis RM. Utilization of Host Polyamines in Alternatively Activated Macrophages Promotes Chronic Infection by Brucella abortus. Infect Immun 2018;86(3):e00458-17. doi:10.1128/IAI.00458-17. https://doi.org/10.1128/IAI.00458-17
  5. Machelart A, Khadrawi A, Demars A, Willemart K, De Trez C, Letesson J-J, Muraille E. Chronic Brucella Infection Induces Selective and Persistent Interferon Gamma-Dependent Alterations of Marginal Zone Macrophages in the Spleen. Infect Immun 2017;85(11):e00115-17. doi:10.1128/IAI.00115-17. https://doi.org/10.1128/IAI.00115-17
  6. Machelart A, Van Vyve M, Potemberg G, Demars A, De Trez C, Tima HG, Vanwalleghem G, Romano M, Truyens C, Letesson J-J, Muraille E. Trypanosoma Infection Favors Brucella Elimination via IL-12/IFNγ-Dependent Pathways. Front Immunol 2017;8:903. doi:10.3389/fimmu.2017.00903. https://doi.org/10.3389/fimmu.2017.00903
  7. Machelart A, Potemberg G, Van Maele L, Demars A, Lagneaux M, De Trez C, Sabatel C, Bureau F, De Prins S, Percier P, Denis O, Jurion F, Romano M, Vanderwinden J-M, Letesson J-J, Muraille E. Allergic Asthma Favors Brucella Growth in the Lungs of Infected Mice. Front Immunol 2018;9:1856. doi:10.3389/fimmu.2018.01856. https://doi.org/10.3389/fimmu.2018.01856
  8. Wang J, Yan Z, Zhang W, Liu X, Wang J, Peng Q. Upregulation of TREM2 expression in M2 macrophages promotes Brucella abortus chronic infection. Front Immunol 2024;15:1466520. doi:10.3389/fimmu.2024.1466520. https://doi.org/10.3389/fimmu.2024.1466520
  9. Mallik SR, Joshi K, Radhakrishnan GK. The arginine/ornithine binding protein ArgT plays an essential role in Brucella neotomae/Brucella melitensis to prevent intracellular killing and contribute to chronic persistence in the host. Virulence 2024;15(1):2421983. doi:10.1080/21505594.2024.2421983. https://doi.org/10.1080/21505594.2024.2421983
  10. Hou S, Kong F, Li X, Xu Y, Chen S, Zhang S, Zhang L, Li T, Fu Y, Li C, Wang W. Role of myeloid-derived suppressor cells in chronic brucellosis. Front Cell Infect Microbiol 2024;14:1347883. doi:10.3389/fcimb.2024.1347883. https://doi.org/10.3389/fcimb.2024.1347883
  11. Barbieux E, Potemberg G, Stubbe F-X, Fraikin A, Poncin K, Reboul A, Rouma T, Zúñiga-Ripa A, De Bolle X, Muraille E. Genome-wide analysis of Brucella melitensis growth in spleen of infected mice allows rational selection of new vaccine candidates. PLoS Pathog 2024;20(8):e1012459. doi:10.1371/journal.ppat.1012459. https://doi.org/10.1371/journal.ppat.1012459
  12. Pellegrini JM, González-Espinoza G, Shayan RR, Hysenaj L, Rouma T, Arce-Gorvel V, Lelouard H, Popoff D, Zhao Y, Hanniffy S, Castillo-Zeledón A, Loperena-Barber M, Celis-Gutierrez J, Mionnet C, Bosilkovski M, Solera J, Muraille E, Barquero-Calvo E, Moreno E, Conde-Álvarez R, Moriyón I, Gorvel J-P, Mémet S. Brucella abortus impairs T lymphocyte responsiveness by mobilizing IL-1RA-secreting omental neutrophils. Nat Commun 2025;16:862. doi:10.1038/s41467-024-55799-2. https://doi.org/10.1038/s41467-024-55799-2
  13. Zhang G, Shen Q, Ye J, Feng Y, Boireau P, Fan X, Lv L, Li Y, Xu X, Cha H, Shen C, Zhang Y, Peng X, Jiang H, Ding J. Single-Cell Transcriptome Profiling Reveals the Immune Dysregulation Characteristics of Mice Infected With Brucella abortus. J Infect Dis 2026;233(1):e55-e66. doi:10.1093/infdis/jiaf522. https://doi.org/10.1093/infdis/jiaf522
  14. Pellegrini JM, Gorvel J-P, Mémet S. Immunosuppressive Mechanisms in Brucellosis in Light of Chronic Bacterial Diseases. Microorganisms 2022;10(7):1260. doi:10.3390/microorganisms10071260. https://doi.org/10.3390/microorganisms10071260
  15. Guimarães ES, Gomes MTR, de Araujo ACVS, Ramos KKS, Oliveira SC. Pathogenicity and virulence of Brucella: Strategies for metabolic adaptation and immune evasion. Virulence 2025;16(1):2585620. doi:10.1080/21505594.2025.2585620. https://doi.org/10.1080/21505594.2025.2585620
  16. Su Y, Zhang L, Liu R, Sa R, Zheng L. Spatiotemporal dynamics of Brucella immune evasion across infection stages. Front Immunol 2026;16:1707297. doi:10.3389/fimmu.2025.1707297. https://doi.org/10.3389/fimmu.2025.1707297
  17. Aziz S, Ahmed A, Singh P, Mukhopadhyay S. The arginase-polyamine signaling axis in immune cells: Implications for immune modulation and host-pathogen interactions. iScience 2026;29(1):114363. doi:10.1016/j.isci.2025.114363. https://doi.org/10.1016/j.isci.2025.114363